Comparison of testosterone, FSH, LH and E2 hormone levels in infertility suspected males with COVID-19 infection

Basit Öğe Kaydı
dc.contributor.authorOzkorkmaz, Ebru Gokalp
dc.contributor.authorBasaran, Suereyya Ozdemir
dc.contributor.authorAfsin, Muhamet
dc.contributor.authorAsir, Firat
dc.date.accessioned2024-04-24T17:08:21Z
dc.date.available2024-04-24T17:08:21Z
dc.date.issued2023
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: Coronavirus disease 2019 (COVID-19) is an infectious disease that has many adverse impacts on many systems including reproduction. The direct effects of COVID-19 on urogenital system are still open to argue. This study aimed to compare testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2) hormone levels in COVID-19 infected male individuals with infertility suspicion.Methods: One hundred five control (healthy) and 105 COVID-19 infected males aged between 20 to 54 years old were enrolled in the study. All patients were either diagnosed with primary or secondary infertility suspicion. The COVID-19 infection was diagnosed via reverse-transcription polymerase chain reaction test. Blood samples from patients were analyzed from the control and COVID-19 group to measure serum testosterone, FSH, LH, and E2 levels. Hormone levels were statistically compared between groups with the Independent T test.Results: In control and COVID-19 patients, no significance was determined for FSH and LH hormone values. Testosterone hormone were significantly decreased and E2 level was statistically increased in COVID-19 patients compared to that in the control group (P < .001).Conclusion: COVID-19 is a viral disease that affects organ including gonads. COVID-19 infection decreased testosterone levels and increased E2 levels, which leading to disorders in male and female reproductivity.en_US
dc.identifier.doi10.1097/MD.0000000000035256
dc.identifier.issn0025-7974
dc.identifier.issn1536-5964
dc.identifier.issue43en_US
dc.identifier.pmid37904470
dc.identifier.scopus2-s2.0-85175593709
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1097/MD.0000000000035256
dc.identifier.urihttps://hdl.handle.net/11468/17311
dc.identifier.volume102en_US
dc.identifier.wosWOS:001124112800056
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofMedicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19en_US
dc.subjectEstradiolen_US
dc.subjectInfertilityen_US
dc.subjectReproductionen_US
dc.subjectTestosteroneen_US
dc.titleComparison of testosterone, FSH, LH and E2 hormone levels in infertility suspected males with COVID-19 infectionen_US
dc.titleComparison of testosterone, FSH, LH and E2 hormone levels in infertility suspected males with COVID-19 infection
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu